Ligand's Partner Melinta Therapeutics Announces U.S. FDA Approval of Baxdela™ (Delafloxacin) for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Press/Media: Press / Media

PeriodJun 20 2017

Media coverage

1

Media coverage